You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. COVID-19

Tixagevimab plus cilgavimab for preventing COVID-19

  • Technology appraisal guidance
  • Reference number: TA900
  • Published:  14 June 2023
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Information about tixagevimab plus cilgavimab
  • 3 Committee discussion
  • 4 Recommendations for research
  • 5 Implementation
  • 6 Evaluation committee members and NICE project team

5 Implementation

Collaboration with Scottish Medicines Consortium

5.1 In Scotland, the advice will have the same status for health board consideration as other Scottish Medicines Consortium advice on new medicines.


Next page 6 Evaluation committee members and NICE project team Previous page 4 Recommendations for research
Back to top